- Home
- PFSI vs CLDX Comparison
PFSI vs CLDX Comparison
Compare PFSI & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFSI | CLDX |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.0B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PFSI | CLDX |
|---|---|---|
| Price | $60.35 | $27.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 15 |
| Target Price | ★ $82.29 | $63.07 |
| AVG Volume (30 Days) | 599.3K | ★ 2.1M |
| Earning Date | 10-29-2026 | 11-09-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | ★ 59.25 | N/A |
| EPS | ★ 1.94 | N/A |
| Revenue | ★ $984,629,000.00 | $12,743,000.00 |
| Revenue This Year | N/A | $19.74 |
| Revenue Next Year | $12.74 | $438.11 |
| P/E Ratio | $31.58 | ★ N/A |
| Revenue Growth | 3.05 | ★ 87.78 |
| 52 Week Low | $57.52 | $22.10 |
| 52 Week High | $160.36 | $45.14 |
Technical Indicators
Market Signals| Indicator | PFSI | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 36.89 | 29.14 |
| Support Level | N/A | $22.39 |
| Resistance Level | $87.46 | $32.16 |
| Average True Range (ATR) | 2.04 | 1.26 |
| MACD | 0.18 | -0.12 |
| Stochastic Oscillator | 38.48 | 1.72 |
Price Performance
Historical ComparisonAbout PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.